439 related articles for article (PubMed ID: 9074303)
1. Substance abuse and cognitive functioning in schizophrenia.
Addington J; Addington D
J Psychiatry Neurosci; 1997 Mar; 22(2):99-104. PubMed ID: 9074303
[TBL] [Abstract][Full Text] [Related]
2. Comorbidity: A sign of the times.
Pivik RT
J Psychiatry Neurosci; 1997 Mar; 22(2):97-8. PubMed ID: 9074302
[No Abstract] [Full Text] [Related]
3. Working memory and depressive symptoms in patients with schizophrenia and substance use disorders.
Potvin S; Pampoulova T; Lipp O; Ait Bentaleb L; Lalonde P; Stip E
Cogn Neuropsychiatry; 2008 Jul; 13(4):357-66. PubMed ID: 18622790
[TBL] [Abstract][Full Text] [Related]
4. Substance use and cognition in early psychosis.
Pencer A; Addington J
J Psychiatry Neurosci; 2003 Jan; 28(1):48-54. PubMed ID: 12587850
[TBL] [Abstract][Full Text] [Related]
5. Relationships between cognitive deficits, symptoms and quality of life in schizophrenia.
Savilla K; Kettler L; Galletly C
Aust N Z J Psychiatry; 2008 Jun; 42(6):496-504. PubMed ID: 18465376
[TBL] [Abstract][Full Text] [Related]
6. Posttraumatic stress disorder, cognitive function and quality of life in patients with schizophrenia.
Fan X; Henderson DC; Nguyen DD; Cather C; Freudenreich O; Evins AE; Borba CP; Goff DC
Psychiatry Res; 2008 May; 159(1-2):140-6. PubMed ID: 18423611
[TBL] [Abstract][Full Text] [Related]
7. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
Liraud F; Verdoux H
Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
[TBL] [Abstract][Full Text] [Related]
8. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
9. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.
Potvin S; Stip E; Lipp O; Roy MA; Demers MF; Bouchard RH; Gendron A
Am J Drug Alcohol Abuse; 2008; 34(1):75-82. PubMed ID: 18161645
[TBL] [Abstract][Full Text] [Related]
10. Neurocognitive functioning in dually diagnosed middle aged and elderly patients with alcoholism and schizophrenia.
Mohamed S; Bondi MW; Kasckow JW; Golshan S; Jeste DV
Int J Geriatr Psychiatry; 2006 Aug; 21(8):711-8. PubMed ID: 16862606
[TBL] [Abstract][Full Text] [Related]
11. Cognitive functioning related to quality of life in schizophrenia.
Matsui M; Sumiyoshi T; Arai H; Higuchi Y; Kurachi M
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):280-7. PubMed ID: 17884266
[TBL] [Abstract][Full Text] [Related]
12. The level of illicit drug use is related to symptoms and premorbid functioning in severe mental illness.
Ringen PA; Melle I; Birkenaes AB; Engh JA; Faerden A; Vaskinn A; Friis S; Opjordsmoen S; Andreassen OA
Acta Psychiatr Scand; 2008 Oct; 118(4):297-304. PubMed ID: 18759810
[TBL] [Abstract][Full Text] [Related]
13. The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues.
Coulston CM; Perdices M; Tennant CC
Aust N Z J Psychiatry; 2007 Nov; 41(11):869-84. PubMed ID: 17924240
[TBL] [Abstract][Full Text] [Related]
14. [Do alcohol or drug abuse induce schizophrenia?].
Hambrecht M; Häfner H
Nervenarzt; 1996 Jan; 67(1):36-45. PubMed ID: 8676987
[TBL] [Abstract][Full Text] [Related]
15. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
[TBL] [Abstract][Full Text] [Related]
16. Is quality of life associated with cognitive impairment in schizophrenia?
Alptekin K; Akvardar Y; Kivircik Akdede BB; Dumlu K; Işik D; Pirinçci F; Yahssin S; Kitiş A
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):239-44. PubMed ID: 15694230
[TBL] [Abstract][Full Text] [Related]
17. [Schizophrenic disorders--does cognitive dysfunction relate to characteristics of course and psychopathology of the illness?].
Wciórka J; Bembenek A; Hintze B; Kühn-Dymecka A
Psychiatr Pol; 2006; 40(5):867-84. PubMed ID: 17217232
[TBL] [Abstract][Full Text] [Related]
18. Community dysfunction in schizophrenia: rate-limiting factors.
Bozikas VP; Kosmidis MH; Kafantari A; Gamvrula K; Vasiliadou E; Petrikis P; Fokas K; Karavatos A
Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):463-70. PubMed ID: 16442195
[TBL] [Abstract][Full Text] [Related]
19. Humor appreciation deficit in schizophrenia: the relevance of basic neurocognitive functioning.
Bozikas VP; Kosmidis MH; Giannakou M; Anezoulaki D; Petrikis P; Fokas K; Karavatos A
J Nerv Ment Dis; 2007 Apr; 195(4):325-31. PubMed ID: 17435483
[TBL] [Abstract][Full Text] [Related]
20. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.
Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R
Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
